overlap (12.0%), while CV/ER have the second lowest incidence (17.6%). This is to the best of our knowledge the first report of such findings.
In balloon-expandable valves, the neo-commissural tabs are not routinely oriented in a specific direction during the crimping process. In self-expanding valves, the tab of one neo-commissure is typically mounted facing the ceiling (top). Besides initial TAV orientation at the time of valve loading, there are certainly other factors that can affect the final deployed TAV orientation relative to the coronaries, including stiff wire position, tortuosity in the arch and descending aorta, and delivery catheter orientation relative to the annulus. Alternative access (eg, transapical, direct aortic) may offer a more direct approach to attempt to avoid overlapping neo-commissures with native coronaries. This may be accomplished by having a more 1-to-1 response to TAV rotation during catheter rotation.
For balloon-expandable valves, the initial TAV orientation when being crimped onto the delivery catheter and the catheter flexibility may affect the final orientation after deployment. Sapien and Sapien XT, given their shorter frame heights, usually would not impede coronary reaccess. In S3, only 24.0% had severe overlap to LCA, 28.0% to RCA, and 17.6% to both. It is possible that the newer generation Commander system with its increased flexibility may reduce the incidence of severe overlap between a neo-commissure and the LCA. We are currently performing a study where we maintain the same S3 crimping orientation on the Commander system and after S3 deployment use fluoroscopy to mathematically correlate with pre-TAVR multidetector computed tomography to determine the neo-commissural orientation relative to the LCA and RCA at the coplanar 3-cusp projection. This may allow us to determine if the initial TAV orientation during crimping may affect final S3 orientation.
In CV, initial mounting to the delivery catheter was done to promote the positioning of neo-commissural tabs away from the LCA. In ER, the C-tab, which identifies one of the neo-commissural tabs, allows the valve to be mounted to the delivery catheter only in a pre-assigned orientation. Interestingly, only 23.5% of CV/ER cases had severe overlap between a neo-commissure and LCA but 47.1% had the same issue with the RCA, while only 17.6% had severe overlap to both. Given the ER delivery catheter has a "hat" marker at the proximal end, pre-orienting the "hat" marker in a certain position across the annulus at the time of ER deployment may affect the final ER orientation.
Our pilot study demonstrated the anatomic relationships between TAV neo-commissures and coronary orifices after TAVR. In 51.4% of cases, a neo-commissure is in the closest proximity to one or both coronary arteries, potentially impacting coronary reaccess after TAVR.
Further investigations are necessary to evaluate the clinical impact of our study.
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